# Dopamine D-2 Antagonist Use in Poor Responders in IVF: a Randomized Controlled Trial

> **NCT02262923** · NA · WITHDRAWN · sponsor: **Mount Sinai Hospital, Canada**

## Conditions studied

- in Vitro Fertilization
- Poor Responder

## Interventions

- **DRUG:** metoclopramide

## Key facts

- **NCT ID:** NCT02262923
- **Lead sponsor:** Mount Sinai Hospital, Canada
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-03
- **Primary completion:** 2018-03
- **Final completion:** 2018-03
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2022-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02262923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02262923, "Dopamine D-2 Antagonist Use in Poor Responders in IVF: a Randomized Controlled Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02262923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*